First Light Asset Management’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-157,147
Closed -$5.54M 76
2023
Q3
$5.54M Sell
157,147
-1,362
-0.9% -$51.9K 0.53% 38
2023
Q2
$6.02M Sell
158,509
-1,516
-0.9% -$60.4K 0.47% 40
2023
Q1
$6.04M Sell
160,025
-238
-0.1% -$9.15K 0.54% 36
2022
Q4
$6.79M Sell
160,263
-1,464
-0.9% -$60.3K 0.63% 36
2022
Q3
$5.2M Buy
161,727
+842
+0.5% +$29.6K 0.53% 41
2022
Q2
$5.23M Sell
160,885
-1,028
-0.6% -$33.3K 0.61% 38
2022
Q1
$5.86M Buy
161,913
+2,966
+2% +$102K 0.52% 37
2021
Q4
$6.29M Sell
158,947
-100,044
-39% -$4.17M 0.45% 44
2021
Q3
$11.3M Sell
258,991
-348,055
-57% -$15.6M 0.75% 38
2021
Q2
$24.8M Sell
607,046
-130,215
-18% -$5.02M 1.49% 28
2021
Q1
$24.2M Buy
737,261
+100,177
+16% +$3.77M 1.6% 25
2020
Q4
$25.9M Buy
637,084
+33,214
+6% +$1.24M 1.92% 21
2020
Q3
$22.1M Buy
603,870
+7,496
+1% +$271K 2.27% 15
2020
Q2
$20.2M Buy
+596,374
New +$16.3M 2.36% 14

Other funds holding GMAB

First Light Asset Management's GMAB Position: Q4 2023 in Review

First Light Asset Management sold out of Genmab (GMAB) in Q4 2023, closing a stake of 157,147 shares — an estimated $5.54M sold.

First Light Asset Management first reported a position in GMAB in Q2 2020 and held it in 14 quarters. The position peaked at $25.9M in Q4 2020. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • First Light Asset Management reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • First Light Asset Management sold 157,147 Genmab shares in Q4 2023, an estimated $5.54M.
  • First Light Asset Management first reported a position in Genmab in Q2 2020 and held it in 14 quarters.
  • First Light Asset Management's Genmab position peaked at $25.9M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on First Light Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.